Drug Shortage Report for STRENSIQ
Report ID | 126804 |
Drug Identification Number | 02444658 |
Brand name | STRENSIQ |
Common or Proper name | ASFOTASE ALFA |
Company Name | ALEXION PHARMA GMBH |
Market Status | MARKETED |
Active Ingredient(s) | ASFOTASE ALFA |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 2ML, 3ML |
ATC code | A16AB |
ATC description | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-02-01 |
Actual start date | |
Estimated end date | |
Actual end date | 2021-06-16 |
Shortage status | Resolved |
Updated date | 2021-09-14 |
Company comments | 80mg/0.8mL (100mg/mL) presentation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | NEUHOFSTRASSE 34 BAAR, -- SWITZERLAND 6340 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-10-21 | English | Compare |
v2 | 2020-10-21 | French | Compare |
v3 | 2020-10-21 | English | Compare |
v4 | 2020-10-21 | French | Compare |
v5 | 2020-12-03 | English | Compare |
v6 | 2020-12-03 | French | Compare |
v7 | 2021-02-02 | English | Compare |
v8 | 2021-09-13 | English | Compare |
v9 | 2021-09-13 | French | Compare |
v10 | 2021-09-14 | English | Compare |
v11 | 2021-09-14 | French | Compare |
Showing 1 to 11 of 11